BioMerieux unveils new sepsis guide at international forum

BioMerieux has announced the launch of the Sepsis Handbook, which is being presented at the International Sepsis Forum in Paris.

The booklet provides an overview of sepsis’ impact on public health, its pathophysiology and the early diagnosis of the condition, reports the firm.

Early diagnosis will be the focus of the guide as it is "critical for improved survival", according to bioMerieux.

Stephane Bancel, chief executive of bioMerieux, stated that in the fight against sepsis, the company must function as a collaborator to healthcare professionals around the world.

"This is why, with contributions from key experts across the globe, we have put together a book to update knowledge on sepsis. I sincerely hope that the information in this book will contribute to improving patient health," he added.

Sepsis is the most common underlying cause of death in non-coronary intensive care units and early recognition of the syndrome is vital for survival of the condition, reports the company.

Earlier this month, bioMerieux agreed a deal with Ipsen to develop a new test for breast cancer.